SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan 
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast 
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target 
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election 
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process 
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand 
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy 
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings 
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates 
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report 
NEW YORK, Nov. 30, 2015 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Texas on behalf of investors who purchased Nobilis Health Corp. (NYSE:HLTH) securities between April 2, 2015 and October 8, 2015.
Click here to learn about the case: http://docs.wongesq.com/HLTH-Info-Request-Form-951. There is no cost or obligation to you.
The complaint alleges that defendants failed to disclose during the Class Period that the Company’s claimed success rates for its AccuraScope procedure lacked recognition from any university, medical body, or insurance company, that the Company overstated its 2014 revenues by as much as $36 million, and that, as a result of the aforementioned, the Company’s 2014 revenue growth rate was actually 44% as opposed to the 161% represented by the Company.
On October 9, 2015, Seeking Alpha published a report on Nobilis asserting, among other things: accounting red flags, questionable marketing practices and substantial insider sales. Shares have fallen from a closing price of $5.24 per share on October 8, 2015, to a close of just $3.06 per share on October 28, 2015.
If you suffered a loss in Nobilis Health you have until December 21, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://docs.wongesq.com/HLTH-Info-Request-Form-951.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
